ENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement — StellaPhase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(31 sites)
South Korea
Bucheon Sejong Hospital, Bucheon-si Gyeongsang National University Changwon Hospital, Changwon Daegu Catholic University Medical Center, Daegu Keimyung University Dongsan Medical Center, Daegu Kyungpook National University Hospital, Daegu Yeungnam University Medical Center, Daegu Chungnam National University Hospital, Daejeon The Catholic University of Korea, Daejeon ST. Mary's Hospital, Daejeon Gangneung Asan Hospital, Gangneung Chonnam National University Hospital, Gwangju Inje University Ilsan Paik Hospital, Ilsan Gachon University Gil Hospital, Incheon Incheon Sejong Hospital, Incheon Inha University Hospital, Incheon The Catholic University of Korea, Incheon St. Mary's Hospital, Incheon Dong-A Medical Center, Pusan Inje University Pusan Paik Hospital, Pusan Pusan National University Hospital, Pusan Seoul university Bundang hospital, Seongnam-si Asan Medical Center, Seoul Ewha Womans University Mokdong Hospital, Seoul Ewha Womans University Seoul Hospital, Seoul Hanyang University Seoul Hospital, Seoul Konkuk University Medical Center, Seoul Korea University Anam Hospital, Seoul Korea University Guro Hospital, Seoul SNU Boramae Medical Center, Seoul The Catholic Univ. of Korea Eunpyeong St. Mary's hospital, Seoul The Catholic University of Korea, ST. Vincent's Hospital, Suwon Uijeongbu Eulji Medical Center, Eulji University, Uijeongbu-si Ulsan University Hospital, Ulsan Age range
19 Years and older
Last updated December 2025